Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul;175(7):1245-7.
doi: 10.1001/jamainternmed.2015.1299.

Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data

Inmaculada Hernandez  1 , Yuting Zhang  1
Affiliations
Comment

Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data

Inmaculada Hernandez et al. JAMA Intern Med. 2015 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and financial disclosure: We have a grant proposal currently under review by Boehringer Ingelheim, which manufactures dabigatran.

Comment on

References

    1. Hernandez I, Baik SH, Pinera A, Zhang Y. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015;175(1):18–24. - PMC - PubMed
    1. Graham DJ, Reichman ME, Wernecke M, et al. Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated with Dabigatran or Warfarin for Non-Valvular Atrial Fibrillation. Circulation. 2014;30(114):012061. - PubMed
    1. Miyares MA. Risk of bleeding with dabigatran in atrial fibrillation; placing real-world results into perspective. JAMA Intern Med. In press. - PubMed
    1. Liu S, Kim CO, Lucyk SN. In Response to Risk of Bleeding with Dabigatran in Atrial Fibrillation. JAMA Intern Med. In press.
    1. Henriksen DP, Hansen MR, Damkier P. Risk of Bleeding With Dabigatran in Atrial Fibrillation. JAMA Intern Med. In press. - PubMed